ProfileGDS4718 / 232863_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 47% 51% 46% 52% 52% 40% 42% 53% 61% 50% 45% 46% 48% 43% 41% 42% 49% 47% 44% 48% 48% 42% 47% 48% 47% 42% 52% 41% 53% 50% 46% 40% 55% 49% 46% 43% 42% 51% 46% 41% 50% 50% 43% 40% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.3672147
GSM549102patient 115, normal, homogenized [OPG study]5.6174151
GSM549104patient 119, normal, homogenized [OPG study]5.2991246
GSM549108patient 138, normal, homogenized [OPG study]5.6708652
GSM549119patient 077, normal, homogenized [OPG study]5.6412552
GSM549133patient 032, cancer, homogenized [OPG study]4.9332440
GSM549139patient 042, cancer, homogenized [OPG study]5.0766142
GSM549099patient 107, normal, homogenized [OPG study]5.6748753
GSM549109patient 139, normal, homogenized [OPG study]6.1926761
GSM549110patient 046, normal, homogenized [OPG study]5.498550
GSM549114patient 063, normal, homogenized [OPG study]5.2098945
GSM549122patient 082, normal, homogenized [OPG study]5.2793946
GSM549134patient 033, cancer, homogenized [OPG study]5.3794348
GSM549136patient 036, cancer, homogenized [OPG study]5.0635343
GSM549140patient 044, cancer, homogenized [OPG study]5.0132441
GSM549111patient 047, normal, homogenized [OPG study]5.0728642
GSM549113patient 057, normal, homogenized [OPG study]5.3859349
GSM549132patient 031, cancer, homogenized [OPG study]5.3145547
GSM549137patient 038, cancer, homogenized [OPG study]5.1535544
GSM549142patient 047, cancer, homogenized [OPG study]5.5563848
GSM549100patient 110, normal, homogenized [OPG study]5.4094948
GSM549107patient 135, normal, homogenized [OPG study]5.0541442
GSM549115patient 068, normal, homogenized [OPG study]5.2856147
GSM549116patient 072, normal, homogenized [OPG study]5.3932348
GSM549120patient 078, normal, homogenized [OPG study]5.3339547
GSM549131patient 030, cancer, homogenized [OPG study]5.0209742
GSM549118patient 074, normal, homogenized [OPG study]5.623652
GSM549129patient 027, cancer, homogenized [OPG study]5.0581241
GSM549123patient 088, normal, homogenized [OPG study]5.6852953
GSM549124patient 006, cancer, homogenized [OPG study]5.5096250
GSM549126patient 015, cancer, homogenized [OPG study]5.2608546
GSM549128patient 025, cancer, homogenized [OPG study]4.9807640
GSM549103patient 117, normal, homogenized [OPG study]5.8610355
GSM549117patient 073, normal, homogenized [OPG study]5.3997249
GSM549138patient 041, cancer, homogenized [OPG study]5.3073546
GSM549141patient 045, cancer, homogenized [OPG study]5.0889743
GSM549130patient 028, cancer, homogenized [OPG study]5.1061942
GSM549101patient 111, normal, homogenized [OPG study]5.6027951
GSM549105patient 128, normal, homogenized [OPG study]5.3113846
GSM549106patient 134, normal, homogenized [OPG study]5.0127941
GSM549112patient 048, normal, homogenized [OPG study]5.5050650
GSM549125patient 011, cancer, homogenized [OPG study]5.5042550
GSM549127patient 024, cancer, homogenized [OPG study]5.1189243
GSM549135patient 035, cancer, homogenized [OPG study]4.9678840